FDA advisers vote to replace original COVID vaccine with biv

Advisers to the U.S. Food and Drug Administration (FDA) on Thursday voted unanimously to replace the original Pfizer and Moderna primary series mRNA COVID-19 vaccines with the bivalent boosters designed to target Omicron variants. The bivalent...

Related Keywords

Wuhan , Hubei , China , Philadelphia , Pennsylvania , United States , Dustin Bryce , Tom Shimabukuro , Peter Marks , Writuparna Das , Josh Guetzkow , Vinay Prasad , Paul Offit , Nicola Klein , Pamela Mcinnes , Centers For Disease , Chicago Medical School , National Institute Of Allergy , Children Health Defense , Drug Administration , Vaccine Education Center , Kaiser Permanente Vaccine Study Center , Pfizer , Infectious Disease Division Of Microbiology , Products Advisory Committee , Rosalind Franklin University , Related Biological Products Advisory Committee , Biologics Evaluation , Rosalind Franklin , Meryl Nass , Health Defense , Disease Control , John Beigel , National Institute , Infectious Disease Division , Infectious Diseases , Safety Datalink , Hayley Gans , Vaccine Safety Datalink , Vaccines Safety Datalink , Vaccine Adverse Events Reporting System , Justin Prince , Emergency Use Authorization ,